title: [Positron emission tomography and stereotactic body radiation therapy for lung cancer: From treatment planning to response evaluation].
abstract: Stereotactic body radiation therapy is the standard treatment for inoperable patients with early-stage lung cancer. Local control rates range from 80 to 90 % 2 years after treatment. The role of positron emission tomography in patient selection is well known, but its use for target definition or therapeutic response evaluation is less clear. We reviewed the literature in order to assess the current state of knowledge in this area.
authors.affiliation: Département de radiothérapie, centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59020 Lille cedex, France.
authors.forename: J-E
authors.initials: JE
authors.lastname: Bibault
authors.affiliation: Service de médecine nucléaire, centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59020 Lille cedex, France.
authors.forename: A
authors.initials: A
authors.lastname: Oudoux
authors.affiliation: Département de radiothérapie, centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59020 Lille cedex, France.
authors.forename: J
authors.initials: J
authors.lastname: Durand-Labrunie
authors.affiliation: Département de radiothérapie, centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59020 Lille cedex, France.
authors.forename: X
authors.initials: X
authors.lastname: Mirabel
authors.affiliation: Département de radiothérapie, centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59020 Lille cedex, France; Faculté de médecine Henri-Warembourg, université Lille 2, 59045 Lille cedex, France; OncoLille, maison régionale de la recherche clinique, 6, rue du Professeur-Laguesse, 59045 Lille cedex, France.
authors.forename: É
authors.initials: É
authors.lastname: Lartigau
authors.affiliation: Service de médecine nucléaire, centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59020 Lille cedex, France. Electronic address: h-gauthier@o-lambret.fr.
authors.forename: H
authors.initials: H
authors.lastname: Kolesnikov-Gauthier
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000601:surgery*; D010347:Patient Care Planning; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D016634:Radiosurgery
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: Définition des volumes; FDG-PET; Follow-up; Metabolic findings; Radiothérapie stéréotaxique; Réponse métabolique; Stereotactic body radiation therapy; Surveillance; TEP-FDG